Alligator Bioscience AB (publ) (STO:ATORX)
Sweden · Delayed Price · Currency is SEK 0.2405
+0.0200 (9.07%)
Apr 24, 2026, 5:29 PM CET
Alligator Bioscience AB Revenue
In the year 2025, Alligator Bioscience AB had annual revenue of 839.00K SEK, down -98.55%. Alligator Bioscience AB had revenue of -3.54M in the quarter ending December 31, 2025.
Revenue
839.00K
Revenue Growth
-98.55%
P/S Ratio
180.05
Revenue / Employee
76.27K
Employees
13
Market Cap
151.06M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 839.00K | -56.88M | -98.55% |
| Dec 31, 2024 | 57.72M | -1.53M | -2.58% |
| Dec 31, 2023 | 59.25M | 23.25M | 64.58% |
| Dec 31, 2022 | 36.00M | 22.67M | 170.14% |
| Dec 31, 2021 | 13.33M | 7.81M | 141.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Xbrane Biopharma AB | 152.35M |
| IRLAB Therapeutics AB | 57.46M |
| Elicera Therapeutics AB | 10.64M |
| NextCell Pharma AB | 9.83M |
| Simris Group AB (PUBL) | 1.62M |
| Diamyd Medical AB | 362.00K |
Alligator Bioscience AB News
- 2 months ago - Alligator Bioscience AB (STU:7AL0) Q4 2025 Earnings Call Highlights: Strategic Advances Amid ... - GuruFocus
- 2 months ago - Q4 2025 Alligator Bioscience AB Earnings Call Transcript - GuruFocus
- 6 months ago - Alligator Bioscience AB (STU:7AL0) Q3 2025 Earnings Call Highlights: Strategic Moves and ... - GuruFocus
- 6 months ago - Q3 2025 Alligator Bioscience AB Earnings Call Transcript - GuruFocus